Literature DB >> 1536277

Prevalence of cocaine use among residents of New York City who committed suicide during a one-year period.

P M Marzuk1, K Tardiff, A C Leon, M Stajic, E B Morgan, J J Mann.   

Abstract

OBJECTIVE: In the mid-1980s the form of cocaine called "crack" became widely available in New York City. The authors sought to determine the prevalence of cocaine metabolites detected at autopsy in persons who committed suicide in New York City during this period.
METHOD: Individual reviews of the autopsy and toxicological records of all persons under the age of 61 who had committed suicide in the city during a 1-year period were conducted to determine demographic characteristics, suicide methods, and cocaine and alcohol use at the time of death.
RESULTS: In one of every five cases studied, the person who committed suicide had used cocaine within days of his or her death. The prevalence of cocaine use among young Hispanic males who committed suicide was 45%. Persons who were young, black, or Hispanic and who had used alcohol immediately before the fatal injury were most likely to have been recent cocaine users. After controlling for demographic variables and ethanol use, the investigators found that individuals who committed suicide with firearms were twice as likely to have used cocaine as those who used other methods.
CONCLUSIONS: In contrast to the results of regional and household surveys during this period, which suggested that the current prevalence of cocaine use in New York City was 3%-5%, these results suggest a high prevalence of cocaine use in the days immediately preceding death by young persons who commit suicide. Additional studies are needed to determine how cocaine may act as a risk factor for suicide.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1536277     DOI: 10.1176/ajp.149.3.371

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  17 in total

Review 1.  Association Between Substance Use and Gun-Related Behaviors.

Authors:  Danhong Chen; Li-Tzy Wu
Journal:  Epidemiol Rev       Date:  2016-01-13       Impact factor: 6.222

Review 2.  Neuropsychiatric effects of cocaine use disorders.

Authors:  Charles U Nnadi; Olubansile A Mimiko; Henry L McCurtis; Jean Lud Cadet
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

3.  Race/ethnicity, substance abuse, and mental illness among suicide victims in 13 US states: 2004 data from the National Violent Death Reporting System.

Authors:  D L Karch; L Barker; T W Strine
Journal:  Inj Prev       Date:  2006-12       Impact factor: 2.399

4.  Cocaine use in the past year is associated with altitude of residence.

Authors:  Kristen K Fiedler; Namkug Kim; Douglas G Kondo; Perry F Renshaw
Journal:  J Addict Med       Date:  2012-06       Impact factor: 3.702

5.  Explaining Changes in the Patterns of Black Suicide in the United States From 1981 to 2002: An Age, Cohort, and Period Analysis.

Authors:  Sean Joe
Journal:  J Black Psychol       Date:  2006-08-01

Review 6.  Substance abuse and suicide risk among adolescents.

Authors: 
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-09       Impact factor: 5.270

7.  Postmortem Presence of Drugs and Method of Violent Suicide.

Authors:  Connor M Sheehan; Richard G Rogers; Jason D Boardman
Journal:  J Drug Issues       Date:  2015-04-29

8.  Gender differences in the presence of drugs in violent deaths.

Authors:  Connor M Sheehan; Richard G Rogers; George W Williams; Jason D Boardman
Journal:  Addiction       Date:  2012-11-01       Impact factor: 6.526

9.  The emergency department in surveillance of attempted suicide: findings and methodologic considerations.

Authors:  G S Birkhead; V G Galvin; P J Meehan; P W O'Carroll; J A Mercy
Journal:  Public Health Rep       Date:  1993 May-Jun       Impact factor: 2.792

Review 10.  Psychosocial interventions for psychostimulant misuse.

Authors:  Silvia Minozzi; Rosella Saulle; Franco De Crescenzo; Laura Amato
Journal:  Cochrane Database Syst Rev       Date:  2016-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.